[Hepatic encephalopathy: long-term therapy with neomycin is problematic].
Held
C
C
Universitätsklinik für Innere Medizin Theodor Brugsch, Medizinische Fakultät (Charité), Humboldt-Universität zu Berlin.
Briedigkeit
H
H
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006319:Hearing Loss, Sensorineural / Q000097:blood / Q000139:chemically induced; D006501:Hepatic Encephalopathy / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects / Q000502:physiology; D007677:Kidney Function Tests; D008106:Liver Cirrhosis, Experimental / Q000097:blood / Q000188:drug therapy*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D051381:Rats
D009355:Neomycin
Hepatische Encephalopathie: Langzeittherapie mit Neomycin problematisch.